Perioperative medicine & outcomes

Preoperative beta blocker use and postoperative ischaemic stroke risk in noncardiac surgery: a multicentre retrospective cohort study

Br J AnaesthPublished Retrospective cohort study

Authors' conclusion

Long-term beta blocker prescription was associated with increased risk of ischaemic stroke within 30 days and up to 365 days after surgery.

Study context

Population
Adults undergoing noncardiac surgery 2005–2021 at two academic healthcare networks in the US
Exposure
Long-term beta blocker prescription vs none within 1 yr before surgery
Outcome
Postoperative ischaemic stroke
Follow-up
30 and 365 days
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Postoperative stroke
Beta blocker vs No beta blockerAdjusted relative risk (95% CI)P value
30 days
1.26(1.17–1.36)
P < 0.001
365 days
1.22(1.16–1.28)
P < 0.001

Observational data: associations, not effects.

Further findings

OutcomeAdjusted RR (95% CI)P value
Stroke within 365 days, by ASA physical status (subgroup)Beta blocker vs No beta blocker · ASA 1-21.96 (1.56–2.45)P < 0.001
Stroke within 365 days, by ASA physical status (subgroup)Beta blocker vs No beta blocker · ASA 3-41.20 (1.15–1.26)P < 0.001
  • Stroke within 365 days, by ASA physical status (subgroup): P for interaction <0.001

Stroke in patients with severe HF (subgroup)

No significant association observed in patients with severe HF

Original publication

Preoperative beta blocker use and postoperative ischaemic stroke risk in noncardiac surgery: a multicentre retrospective cohort study. Br J Anaesth. Published 8 January 2026. doi:10.1016/j.bja.2025.11.027

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.